NIH wants to give Gilead a new, government subsidized monopoly on CAR T technology, this one for CD-30 proteins. Posted on January 5, 2018 by James Love We have a briefing note on this license here: 2018: Briefing note on NIH proposed license to Gilead for CD-30 CAR T technology
